Skip to main content
Unjha Formulations Ltd. logo

Unjha Formulations Ltd. — Investor Relations & Filings

Ticker · 531762 ISIN · INE576D01015 LEI · 335800M2JJM1Z2BQCW90 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-18 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 531762

About Unjha Formulations Ltd.

https://www.unjhaformulations.com/

Unjha Formulations Ltd. specializes in the development, manufacture, and marketing of Ayurvedic and herbal healthcare products. The company integrates traditional Ayurvedic principles with modern manufacturing processes to produce a diverse range of therapeutic formulations. Its product portfolio includes classical Ayurvedic medicines, proprietary formulations, health supplements, and wellness products available in various delivery formats such as tablets, syrups, churnas, oils, and ointments. Unjha Formulations serves markets seeking natural and holistic healthcare solutions, emphasizing quality control and the use of authentic herbal ingredients. The company’s operations encompass the entire value chain from the sourcing of raw botanical materials to final distribution, catering to both chronic and acute health conditions through its extensive range of natural remedies.

Recent filings

Filing Released Lang Actions
INTEGRATED FILING
Interim / Quarterly Report Classification · 85% confidence The document is a submission letter to the stock exchange under SEBI circulars, enclosing the company’s financial results (“Integrated Filing (Financials)”) for the quarter and year ended March 31, 2026. It includes actual financial statements, schedules on audit qualifications, related party transactions, etc. This matches a comprehensive interim/quarterly financial report rather than just an earnings highlight, an annual report, or a mere announcement. Therefore, it should be classified as an Interim / Quarterly Report. FY 2026
2026-05-18 English
REGULATION 33 OF SEBI LODR 2015
Interim / Quarterly Report Classification · 85% confidence The document is a formal filing to the stock exchange under SEBI (LODR) Regulation 33, containing the company’s audited financial results for the quarter and year ended March 31, 2026, including the balance sheet, profit & loss, cash flow statement and the Independent Auditor’s Report. It is not merely an earnings release or announcement of a report but presents full financial statements for the quarter (a period shorter than the fiscal year) and year. This aligns with our “Interim / Quarterly Report” category, which requires substantive financial data and statements for a period shorter than a full fiscal year (the quarter). FY 2026
2026-05-18 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.